Dave Clissold Named to ACTION Board of Advisors


June 15, 2011

Dave Clissold has been named to the Board of Advisors of Analgesic Clinical Trial Innovations, Opportunities, and Networks (“ACTION”). ACTION is a public-private partnership aligned with FDA’s recently launched Initiative for the Advancement of Regulatory Science. ACTION is designed to benefit the public health by streamlining the discovery and development process for new analgesic medications.